Explorer
Covaxin demonstrates protection against deadly new variants
A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.
A modest reduction in neutralization by a factor of 1.95 was observed against B1617 variant compared to vaccine variant.
India
Breaking: NEET Paper Leak Case Hearing Delayed as CBI Lawyer Fails to Appear in Fast Track Court
Breaking: Viral Girl Riya Ahir Reports Online Threats, Files Complaint With Cyber Crime Police
Political War Over Student Protest: Opposition Targets Government After Bihar AK-47 Firing Row
Student Tragedy: Maharashtra NEET Aspirant Dies by Suicide, Re-Exam Scores Mentioned in Note
Political Update: Dharmendra Pradhan Receives Grand Welcome From BJP MPs After Stepping Down as Minister
View More
Trending News




















